JeNaCell

Photo
10.08.2021 • News

Evonik Acquires German Biotech JeNaCell

For an undisclosed sum, Germany’s Evonik has acquired German industrial biotech JeNaCell, thereby expanding its biomaterials portfolio to biotechnologically derived cellulose. The Essen-based group said the acquisition confirms its venture capital arm’s strategy of investing early in start-ups with visionary technology relevant to its own innovation growth fields.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.